Evan Feely

Evan Feely serves as a key procurement lead within the National Institute on Drug Abuse (NIDA), supporting the agency’s mission to advance scientific research on substance use disorders through strategic acquisition of technical and scientific services. He manages a diverse portfolio of research-focused contracts, primarily facilitating the procurement of laboratory instrumentation, biomedical research services, and specialized consulting to enable cutting-edge neurobiological and behavioral studies. His acquisitions are critical to translating laboratory findings into clinical and public health applications, ensuring that NIDA’s funded research infrastructure remains at the forefront of scientific innovation. Feely maintains consistent working relationships with leading academic and research institutions, including The McLean Hospital Corporation, the University of Maryland Baltimore, the University of Miami, the University of Pittsburgh, and the Icahn School of Medicine at Mount Sinai. These partnerships are typically structured as research support contracts, service agreements, and instrument procurement vehicles, reflecting a preference for high-capacity academic research entities with proven expertise in addiction science and translational neuroscience. His contracting patterns show a strong emphasis on open competition, with 67.7% of awards issued without set-asides, while maintaining a robust commitment to small business participation—30.4% of awards are designated as total small business set-asides under FAR 19.5, with a modest but consistent focus on women-owned small businesses. This balance reflects a strategic approach that prioritizes scientific excellence while fostering broad vendor engagement. Feely’s procurement activity is heavily concentrated in NAICS 334516 (analytical laboratory instrument manufacturing) and 541690 (other scientific and technical consulting services), underscoring his specialization in procuring advanced research equipment and expert analytical services. His domain expertise spans neuroimaging systems, behavioral assessment tools, and data analytics platforms essential to modern addiction research.